NasdaqGS - Nasdaq Real Time Price USD
Fortrea Holdings Inc. (FTRE)
5.58
+0.26
+(4.89%)
As of 10:37:41 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
262,800
262,800
168,400
82,700
169,800
Investing Cash Flow
251,600
251,600
-31,800
-54,000
-26,200
Financing Cash Flow
-497,800
-497,800
-140,800
-6,300
-128,500
End Cash Position
118,500
118,500
108,600
110,400
94,600
Capital Expenditure
-25,500
-25,500
-40,300
-54,400
-26,500
Issuance of Debt
826,500
826,500
1,795,400
--
--
Repayment of Debt
-1,309,200
-1,309,200
-179,400
--
--
Free Cash Flow
237,300
237,300
128,100
28,300
143,300
12/31/2021 - 6/20/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCYC Bicycle Therapeutics plc
8.68
+0.12%
MGTX MeiraGTx Holdings plc
6.52
+0.39%
ENTA Enanta Pharmaceuticals, Inc.
5.45
-2.68%
DYN Dyne Therapeutics, Inc.
11.03
+2.32%
GMAB Genmab A/S
20.44
+1.54%
MBX MBX Biosciences, Inc.
9.57
+6.40%
CGEM Cullinan Therapeutics, Inc.
8.41
+0.36%
IMVT Immunovant, Inc.
14.86
+2.84%
INVA Innoviva, Inc.
18.49
+0.65%
NUVL Nuvalent, Inc.
72.97
+0.36%